Quadrupling inhaled corticosteroid doses.
作者信息
Kouri Andrew, Kaplan Alan, Gupta Samir
机构信息
Toronto, Ont.
出版信息
Can Fam Physician. 2019 Jul;65(7):456-457.
Abstract
摘要
相似文献
1
Quadrupling inhaled corticosteroid doses.将吸入性糖皮质激素剂量增加四倍。
Can Fam Physician. 2019 Jul;65(7):456-457.
2
Is there adequate evidence for quadrupling inhaled corticosteroid doses?将吸入性糖皮质激素剂量增加至四倍是否有充分的证据？
Can Fam Physician. 2019 May;65(5):313-314.
3
Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.将吸入性糖皮质激素剂量增至四倍以预防哮喘加重：一项随机、双盲、安慰剂对照、平行组临床试验。
Am J Respir Crit Care Med. 2009 Oct 1;180(7):598-602. doi: 10.1164/rccm.200904-0616OC. Epub 2009 Jul 9.
4
Relationship between changes in inhaled corticosteroid use and markers of uncontrolled asthma during pregnancy.怀孕期间吸入性皮质类固醇使用的变化与哮喘未控制的标志物之间的关系。
Pharmacotherapy. 2012 Mar;32(3):202-9. doi: 10.1002/j.1875-9114.2012.01091.x.
5
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.皮质类固醇药物遗传学：CRHR1基因序列变异与吸入皮质类固醇治疗的哮喘患者肺功能改善的关联
Hum Mol Genet. 2004 Jul 1;13(13):1353-9. doi: 10.1093/hmg/ddh149. Epub 2004 May 5.
6
Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma.皮质类固醇依赖型哮喘中支气管上皮细胞的增殖与激活
J Allergy Clin Immunol. 2001 Nov;108(5):738-46. doi: 10.1067/mai.2001.119160.
7
Quadrupling or quintupling inhaled corticosteroid doses to prevent asthma exacerbations: the jury's still out.
Arch Dis Child Educ Pract Ed. 2019 Jun;104(3):166-167. doi: 10.1136/archdischild-2018-315608. Epub 2018 Jul 24.
8
Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.哮喘孕妇使用长效β₂-激动剂和吸入皮质类固醇联合治疗与高剂量吸入皮质类固醇单一疗法相比的先天畸形风险。
J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051. Epub 2014 Sep 13.
9
10
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective.稳定期哮喘患者减量吸入性糖皮质激素治疗：二级医疗视角
QJM. 2005 Oct;98(10):771-2. doi: 10.1093/qjmed/hci117.
本文引用的文献
1
Is there adequate evidence for quadrupling inhaled corticosteroid doses?将吸入性糖皮质激素剂量增加至四倍是否有充分的证据？
Can Fam Physician. 2019 May;65(5):313-314.
2
New evidence-based tool to guide the creation of asthma action plans for adults.新的基于证据的工具，用于指导成人哮喘行动计划的制定。
Can Fam Physician. 2019 Feb;65(2):103-106.
3
Large care gaps in primary care management of asthma: a longitudinal practice audit.初级保健中哮喘管理的巨大护理差距：一项纵向实践审计。
BMJ Open. 2019 Jan 29;9(1):e022506. doi: 10.1136/bmjopen-2018-022506.
4
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.全身性皮质类固醇激素用于哮喘治疗引发的不良后果：长期观察性研究。
J Asthma Allergy. 2018 Aug 29;11:193-204. doi: 10.2147/JAA.S176026. eCollection 2018.
5
Inhaled Glucocorticoids in Asthma.哮喘中的吸入性糖皮质激素
N Engl J Med. 2018 May 24;378(21):2050-1. doi: 10.1056/NEJMc1804801.
6
Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations.加倍吸入糖皮质激素剂量以终止哮喘恶化。
N Engl J Med. 2018 Mar 8;378(10):902-910. doi: 10.1056/NEJMoa1714257. Epub 2018 Mar 3.
7
Solving the mystery of the yellow zone of the asthma action plan.解开哮喘行动计划黄色区域之谜。
NPJ Prim Care Respir Med. 2018 Jan 11;28(1):1. doi: 10.1038/s41533-017-0067-1.
8
An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.一种基于证据的即时护理工具，用于指导在实际操作中完成哮喘行动计划。
Eur Respir J. 2017 May 1;49(5). doi: 10.1183/13993003.02238-2016. Print 2017 May.
9
Systematic meta-review of supported self-management for asthma: a healthcare perspective.哮喘支持性自我管理的系统综述：医疗保健视角
BMC Med. 2017 Mar 17;15(1):64. doi: 10.1186/s12916-017-0823-7.
10
Chronic disease management programmes for adults with asthma.针对成年哮喘患者的慢性病管理项目。
Cochrane Database Syst Rev. 2015 May 27;2015(5):CD007988. doi: 10.1002/14651858.CD007988.pub2.
Zotero 插件